Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,998 | 53,391 | 59,928 | 65,325 | 72,904 |
| TOTAL | $49,381 | $54,366 | $61,029 | $66,456 | $74,506 |
| Non-Current Assets | |||||
| PPE Net | 295 | 226 | 271 | 317 | 364 |
| Other Non-Current Assets | 2,099 | 1,559 | 1,717 | 1,874 | 2,029 |
| TOTAL | $2,394 | $1,785 | $1,988 | $2,191 | $2,393 |
| Total Assets | $51,775 | $56,151 | $63,017 | $68,647 | $76,899 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,247 | 6,224 | 7,714 | 6,520 | 7,568 |
| TOTAL | $7,969 | $6,834 | $8,314 | $7,110 | $8,148 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 972 | 531 | 685 | 836 | 984 |
| TOTAL | $35,972 | $35,533 | $35,690 | $35,843 | $35,993 |
| Total Liabilities | $43,941 | $42,367 | $44,004 | $42,953 | $44,141 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,375 | 31,196 | 31,196 | 31,196 | 31,196 |
| Common Shares | 31 | 31 | 31 | 31 | 31 |
| Retained earnings | -409,713 | -403,773 | -398,642 | -391,764 | -375,826 |
| Other shareholders' equity | -20 | 0 | 0 | 0 | 0 |
| TOTAL | $7,834 | $13,784 | $19,013 | $25,694 | $32,758 |
| Total Liabilities And Equity | $51,775 | $56,151 | $63,017 | $68,647 | $76,899 |